September #182 : Generic Drugs in the U.S.? - by Laura Whitehorn

POZ - Health, Life and HIV
Subscribe to:
POZ magazine
Join POZ: Facebook MySpace Twitter Pinterest
Tumblr Google+ Flickr MySpace
POZ Personals
Sign In / Join

Back to home » Archives » POZ Magazine issues

Table of Contents


Healing the Hurt

Hot on the Trail

From the Editor

The Not-So-Weaker Sex


Letters- September 2012


The Accidental Historian

What You Need to Know

Not So Sacred Bonds of Marriage

Mo Money, Mo Health

Easing the Pain of Adult Male Circumcision?

Fifty Shades of HIV?

Digital Disease Detector

We Hear You

There's No Place Like Home

POZ Survey Says

Take Good Care

What Matters to You

Clarifying HIV Heart Disease Risk

Overturning the Gay Blood Ban

Treatment News

Generic Drugs in the U.S.?

Is He or Isn’t He Cured? Real Answers to the Case of the Berlin Patient

More Safer Sex

Common Sense Rules the Court

GMHC Treatment Issues September 2012

Comfort Zone

Making Cents of Health Insurance

POZ Heroes

Midnight Cowboy

Most Popular Lessons

The HIV Life Cycle


Herpes Simplex Virus

Syphilis & Neurosyphilis

Treatments for Opportunistic Infections (OIs)

What is AIDS & HIV?

Hepatitis & HIV

email print

September 2012

Generic Drugs in the U.S.?

by Laura Whitehorn

Bernie SandersAntiretroviral HIV meds cost as much as $25,000 a year in the United States, but only hundreds of dollars in the developing world. Why? Generic versions of some HIV drugs are available internationally via the President’s Emergency Plan for AIDS Relief (PEPFAR) and other global health progams. With more than 750,000 Americans with HIV not getting treatment and given that part of the reason is cost, we need to make drugs affordable for the 30 percent of HIV-positive Americans who have no insurance. Waiting lists remain for AIDS Drug Assistance Programs (ADAPs); federally subsidized government funding for AIDS is under attack; and more and more states are cutting back on Medicaid.  

U.S. Senator Bernie Sanders (I-Vt.) has proposed one solution. In May, Sanders submitted a bill to Congress to create a $3 billion prize fund for developers of new HIV meds. The money would be given in exchange for allowing a new drug to go generic right away, replacing the patents that currently keep prices high. At press time, the bill—the Prize Fund for HIV/AIDS Act—remained in committee.

Search: Antiretroviral medication, ARV, generic, PEPFAR, ADAP, Prize Fund for HIV/AIDS Act, U.S. Senator Bernie Sanders

Scroll down to comment on this story.


(will display; 2-50 characters)


(will NOT display)


(will display; optional)

Comment (500 characters left):

(Note: The POZ team reviews all comments before they are posted. Please do not include either ":" or "@" in your comment. The opinions expressed by people providing comments are theirs alone. They do not necessarily reflect the opinions of Smart + Strong, which is not responsible for the accuracy of any of the information supplied by people providing comments.)

Comments require captcha.
Please enter this number for verification:

| Posting Rules

Hide comments

Previous Comments:


[Go to top]

Facebook Twitter Google+ MySpace YouTube Tumblr Flickr Instagram
Quick Links
Current Issue

HIV Testing
Safer Sex
Find a Date
Newly Diagnosed
HIV 101
Disclosing Your Status
Starting Treatment
Help Paying for Meds
Search for the Cure
POZ Stories
POZ Opinion
POZ Exclusives
Read the Blogs
Visit the Forums
Job Listings
Events Calendar
POZ on Twitter

Ask POZ Pharmacist

Talk to Us
Did you participate in an event for National Black HIV/AIDS Awareness Day 2016?


more surveys
Contact Us
We welcome your comments!
[ about Smart + Strong | about POZ | POZ advisory board | partner links | advertising policy | advertise/contact us | site map]
© 2016 Smart + Strong. All Rights Reserved. Terms of use and Your privacy.
Smart + Strong® is a registered trademark of CDM Publishing, LLC.